Anavex Life Sciences Corp (AVXL)

[Investor2014]

As good as it gets with observation based scoring and never seen better in Rett.

I think with a rare orphaned disease this is good enough even without a recognised strongly correlated objective biomarker, cause no one knows of one.

It would have been even better with a recognised and strongly correlated objective biomarker. I think the market sort of automatically is looking for that, but I think we got this especially once EXCELLENCE readouts.

IMO we need to wait for EXCELLENCE before an approval process kicks in.